Stock screener

ARWR

Conviction 27HealthcareScan · Thu, Sep 24, 2026

Arrowhead Pharmaceuticals, Inc. (ARWR) closed at $66.06 (-1.34%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 31, RS Rating 94, -26.3% from its 52-week high, -2.5% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

ARWR$66.06-1.34%
ResistanceSupportVol 14Insider sell
63 bars
2
Vol MA14 2.6M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
ARROWHEAD PHARMACEUTICALS, INC.PHARMACEUTICAL PREPARATIONSwww.arrowheadpharma.com ↗
Price66.06
Change-1.34%
Gap+0.69%
Rel volume0.90×
Avg volume2.22M
Avg $ vol164.69M
SMA 2077.76
SMA 5082.32
SMA 20072.60
Price vs 50-19.75%
Price vs 200-9.01%
MA stackmixed
50/200 cross—
Supertrenddown · 78.71
RSI (14)31
MACD hist-1.34
MACD cross—
Stoch %K / %D7 / 17
ADX (14)26
+DI / −DI16 / 35
RSI divergence—
MACD divergence—
ATR %6.06%
ADR %5.22%
52w high89.59
52w low31.66
From 52w high-26.26%
Above 52w low+108.65%
New 52w highNo
SqueezeOff
Bollinger width42.25%
%B0.14
Donchian pos6.22%
Donchian high89.59
Donchian low64.50
AVWAP (52w high)80.98
vs AVWAP high-18.42%
AVWAP (52w low)65.76
vs AVWAP low+0.45%
OBV trendDown
Chaikin MF (20)-0.27
Today vs 20d0.90×
Avg vol (14d)2.6M
Avg vol (20d)2.22M
Avg $ vol (20d)164.69M
Market cap9.33B
RS Rating94 / 99
RS 3m (vs SPY)-21.16%
RS 6m (vs SPY)-8.11%
RS line new highNo
Trend template4/8
Technical rank30.1
1 week-2.48%
1 month-25.68%
3 months-16.66%
6 months+8.70%
1 year+103.26%
YTD-2.55%
P/E-5721.20
P/B20.04
P/S11.25
P/FCF59.48
EPS-0.0100
Div yield—
ROE-0.35%
ROA-0.08%
Debt/Eq—
Current5.90
EV/EBITDA76.83
Gross margin—
Net margin-0.20%
Rev growth—
EPS growth99.73%
Price target109.11
Target upside65.17%
Analyst ratingBuy
Institutional96.35%
Ent. value9.26B
Revenue75.25M
Net income-194.28M
Gross profit—
Free cash flow156.89M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out140.86M
Employees711
ListedWed, Feb 1, 1995
Free float134.77M
Float %96.2%
Short interest9.43M
Days to cover8.8d
Short volume59.4%
Squeeze score52 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.36 vs −$1.23
Last surprise-10.6% miss
Setup gradeD
Conviction27 / 100
Pattern quality—
Tech rank30.1 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance90.66
Support65.28
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Recent news

Congress activity

Disclosed STOCK Act trades in ARWR

All disclosures →
No recent disclosed trades by Congress in ARWR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ARWR · open-market 7 sells

InsiderSideShares
OLUKOTUN ADEOYE Y
Director · Common Stock · 2026-08-18
Sell2K
PERRY MICHAEL S
Director · Common Stock · 2026-08-18
Sell11.6K
Cohen Matthew Gregory
Director · Common Stock · 2026-06-15
Grant11.88K
Lu Hongbo
Director · Common Stock · 2026-05-12
Sell2.97K
Hamilton James C
Chief Medical Officer · Common Stock · 2026-04-23
Sell10K
Apel Daniel Joseph
Chief Financial Officer · Common Stock · 2026-04-22
Sell3.21K
Apel Daniel Joseph
Chief Financial Officer · Common Stock · 2026-04-22
Sell8.73K
Apel Daniel Joseph
Chief Financial Officer · Common Stock · 2026-04-22
Sell1.16K

SEC filings

EDGAR filings in ARWR · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.